Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of bimekizumab in palmoplantar pustulosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Pustulosis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Palmoplantar Pustulosis | Phase 3 | Status: RECRUITING